Hospitals fight drug scarcity, fear patients harmed
The growing scarcity of sterile, injectable drugs is one of the biggest issues confronting hospitals across the country, and will be a key issue at the annual American Society of Clinical Oncology meeting in Chicago this weekend. Health officials blame the shortages on industry consolidation that has left only a handful of generic manufacturers of these drugs, even as the number of drugs going off-patent is growing. Some drugmakers have been plagued by manufacturing problems that have shut down multiple plants or production lines, while others have stopped producing a treatment when profit margins erode too far.
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Hard-Nosed About Physician Teamwork
- Quiet ORs Better for Patient Safety
- Building a Better Healthcare Board
- Case Study: Advance Care Conversations
- Tavenner Confirmed as CMS Administrator
- CMS Releases Hospital Pricing Data
- Leapfrog Hospital Safety Scores 'Depressing'
- Access to EHR Notes Lauded by Patients, Providers